UPClytics
ENDE
Sign inStart trial
View all cases

UPC CFI 657/2025

Jul 17, 2025·EP2697391 · METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE

Follow
Case details
Status
Case Closed
Action
Generic
Category
Costs assessments
Parties
Claimants
Representatives
Respondents
Representatives
Division
Dusseldorf LD
Judges
Technology
  • Chemistry
    Biotechnology
Language
English
First decided
Feb 2, 2026
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Dusseldorf LDLocked
Judge Ronny ThomasLocked
Judge Berenice ThomLocked
Judge András KupeczLocked
Judge Martin SchmidtLocked

At the UPC: Curio Bioscience Inc. (19 cases)·10x Genomics, Inc. (40 cases)

Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent

This dispute contains 18 other proceedings

UPC CFI 658/2025·UPC CoA 805/2024·UPC CoA 810/2024·UPC CoA 234/2024·UPC CFI 140/2024 and 13 more

Start a free trial to see how each one ended.

More cases: Dusseldorf LD·2025

Decisions
  • 2026-02-02
    Public

    Summary: The Düsseldorf Local Division issued a cost decision following the merits judgment of 16 June 2025 (10x Genomics v. Curio Bioscience), apportioning costs of PI proceedings and main action proceedings at a 30%/70% ratio (claimant/defendant) based on the parties' respective success.

    Show the legal issues (3)
    • Cost apportionment (Art. 69 UPCA)
    • Reasonable and proportionate costs
    • Combined PI and merits cost proceedings
Documents
Show all 45 documents
Document titleDatePublic
Case closed2026-07-28Not public
Decision2026-02-02Not public
Decision2026-02-02Public
Decision2026-02-02Not public
Receipt2026-01-26Not public
Cover sheet2026-01-26Not public
Other document Defendant2026-01-26Not public
Order2026-01-19Not public
Order2026-01-19Public
Receipt2026-01-19Not public